Unlocking NuriPep 1653 From Common Pea Protein: A Potent Antimicrobial Peptide to Tackle a Pan-Drug Resistant Acinetobacter baumannii

被引:19
作者
Mohan, Niamh Maire [1 ,2 ]
Zorgani, Amine [2 ]
Jalowicki, Gael [2 ]
Kerr, Alish [2 ]
Khaldi, Nora [2 ]
Martins, Marta [1 ]
机构
[1] Univ Dublin, Trinity Coll Dublin, Sch Genet & Microbiol, Dept Microbiol,Moyne Inst Prevent Med, Dublin, Ireland
[2] Nuritas Ltd, Dublin, Ireland
来源
FRONTIERS IN MICROBIOLOGY | 2019年 / 10卷
关键词
antimicrobial peptides; multidrug resistance; Acinetobacter baumannii; data mining; hydrolyzed proteins; novel antimicrobials; BIOACTIVE PEPTIDES; BACTERIA;
D O I
10.3389/fmicb.2019.02086
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
While the antibiotic era has come and gone, antimicrobial peptides (AMPs) hold promise as novel therapies to treat multidrug resistant (MDR) pathogens in an age where the threat of multidrug resistance escalates worldwide. Here, we report the bactericidal properties of NuriPep 1653, a novel 22 mer and non-modified peptide. NuriPep 1653 was identified within the sequence of the non-antimicrobial P54 protein, which is involved in nutrient reservoir activity in Pisum sativum. Total bacterial clearance of Acinetobacter baumannii cells (1 x 10(8) cells/mL) was observed using only 4 x MIC (48 mu g/mL) of NuriPep 1653 after just 20 min of treatment. We uncovered a synergistic interaction between NuriPep 1653 and another antimicrobial peptide, colistin. The MIC of NuriPep 1653 and colistin dropped from 12 and 8 mu g/mL to 2 and 1 mu g/mL, respectively, when they were combined. NuriPep 1653 exhibits no cytotoxicity in different human cell lines and has a low propensity to induce bacterial resistance in a colistin resistant clinical isolate of A. baumannii. The existence of these peptides embedded in proteins unearths potentially new classes of antimicrobials with activity against clinically relevant pathogens. Our findings push the boundaries of traditional peptide discovery and represent a leading edge for natural bioactive compounds which may have a common existence in nature but remain unexposed.
引用
收藏
页数:16
相关论文
共 45 条
[1]  
Ahmed SS, 2016, J INFECT DIS THER, V4, P287, DOI DOI 10.4172/2332-0877.1000287
[2]  
[Anonymous], 2014, EuPA Open Proteomics, DOI DOI 10.1016/J.EUPROT.2014.05.003
[3]   Antimicrobial Peptides [J].
Bahar, Ali Adem ;
Ren, Dacheng .
PHARMACEUTICALS, 2013, 6 (12) :1543-1575
[4]   Antimicrobial Peptides - Promising Alternatives to Conventional Antibiotics [J].
Baltzer, Sylvia A. ;
Brown, Melissa H. .
JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY, 2011, 20 (04) :228-235
[5]   Antimicrobial Activity of Lactoferrin-Related Peptides and Applications in Human and Veterinary Medicine [J].
Bruni, Natascia ;
Capucchio, Maria Teresa ;
Biasibetti, Elena ;
Pessione, Enrica ;
Cirrincione, Simona ;
Giraudo, Leonardo ;
Corona, Antonio ;
Dosio, Franco .
MOLECULES, 2016, 21 (06)
[6]   A 6 x 6 drop plate method for simultaneous colony counting and MPN enumeration of Campylobacter jejuni, Listeria monocytogenes, and Escherichia coli [J].
Chen, CY ;
Nace, GW ;
Irwin, PL .
JOURNAL OF MICROBIOLOGICAL METHODS, 2003, 55 (02) :475-479
[7]  
CLSI, 2013, PERF STAND ANT SUS S
[8]   Enzymes in Human Milk [J].
Dallas, David C. ;
German, J. Bruce .
INTESTINAL MICROBIOME: FUNCTIONAL ASPECTS IN HEALTH AND DISEASE, 2017, 88 :129-136
[9]   Engineered Cationic Antimicrobial Peptides To Overcome Multidrug Resistance by ESKAPE Pathogens [J].
Deslouches, Berthony ;
Steckbeck, Jonathan D. ;
Craigo, Jodi K. ;
Doi, Yohei ;
Burns, Jane L. ;
Montelaro, Ronald C. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (02) :1329-1333
[10]  
Ehrlich P., 1892, Medical Microbiology and Immunology, V12, P183